Matches in Wikidata for { <http://www.wikidata.org/entity/Q65473392> ?p ?o ?g. }
Showing items 1 to 29 of
29
with 100 items per page.
- Q65473392 description "clinical trial" @default.
- Q65473392 description "ensayu clínicu" @default.
- Q65473392 description "klinisch onderzoek" @default.
- Q65473392 description "клінічне випробування" @default.
- Q65473392 name "Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects" @default.
- Q65473392 name "Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects" @default.
- Q65473392 type Item @default.
- Q65473392 label "Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects" @default.
- Q65473392 label "Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects" @default.
- Q65473392 prefLabel "Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects" @default.
- Q65473392 prefLabel "Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects" @default.
- Q65473392 P1132 Q65473392-2D777AEF-7B1E-4348-A14A-EDDDC1E36B44 @default.
- Q65473392 P1476 Q65473392-235A422F-1861-41A9-ACE9-ACCBE1BC47DB @default.
- Q65473392 P17 Q65473392-7FA664E3-4755-4582-A0E1-39B82F2419E2 @default.
- Q65473392 P2899 Q65473392-C822B8CF-2404-4C60-BA49-B428697CD0AB @default.
- Q65473392 P3098 Q65473392-0655A987-03A2-4C29-AA30-CC4C6B711C9B @default.
- Q65473392 P31 Q65473392-27626700-1520-4184-B60B-02042744BC4E @default.
- Q65473392 P580 Q65473392-12B664B7-A64F-4D8E-8B67-D0D5CD0571DA @default.
- Q65473392 P6099 Q65473392-2533A58A-C068-4951-9DB1-A29374DC8D47 @default.
- Q65473392 P8363 Q65473392-73EFEE20-B9CC-42F6-BBD7-4BEEA4142737 @default.
- Q65473392 P1132 "+520" @default.
- Q65473392 P1476 "A Phase II, Randomized, Controlled, Observer-Blind, Multi-Center Study to Evaluate Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two (Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines Containing 7.5 mg or 15 mg of H5N1 Influenza Antigen, in Non-Elderly Adult and Elderly Subjects" @default.
- Q65473392 P17 Q38 @default.
- Q65473392 P2899 "+18" @default.
- Q65473392 P3098 "NCT00311480" @default.
- Q65473392 P31 Q30612 @default.
- Q65473392 P580 "2006-03-01T00:00:00Z" @default.
- Q65473392 P6099 Q42824440 @default.
- Q65473392 P8363 Q78089383 @default.